ClinicalTrials.govpublic full text
Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT
cetuximab-induced papulopustular (acneiform) rash who have, metastatic colorectal cancer or head and neck squamous cell carcinoma, topical dapsone 5% gel, moisturizer, rash, 13-012, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854377
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.